British Journal of Haematology · 1997 · 49 citations · 7 references
MedicineCancer BiologyOncologyChemotherapyTumor ImmunologyTumor ProgressionCalcium SignalingCancer Cell SignalingCytokine Receptor SignalingCytokines In Tumor ImmunityMalignant NeoplasmsOvarian CancerCytokine Signaling In CancerCytokine Signaling In TumorsInflammatory Cytokine ProfilesLymphoma PathogenesisTumor-associated Cytokines
We report a 53-year-old-man with an aggressive Ki-1 lymphoma who had high serum CA125, a marker protein of the epithelial ovarian cancer, and interleukin-6 (IL-6) concentrations. Both CA125 and IL-6 levels decreased after chemotherapy and elevated with disease progression. The patient's lymphoma cells obtained before chemotherapy grew continuously in vitro, were IL-6 dependent and were found to secrete CA125 in culture medium. These results indicate that CA125 can be secreted by Ki-1 lymphoma cells and IL-6 may promote the growth of Ki-1 lymphoma cells.
7
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Robert C. Bast, Maryellen Feeney, Herbert Lazarus et al. · Journal of Clinical Investigation · 1981 · 1.7K citations · Full text
Medicine, Cancer Biology, Oncology +17
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Michio Kawano, Toshio Hirano, Tadashi Matsuda et al. · Nature · 1988 · 1.7K citations
Medicine, Immunology, Oncology +11